BiomX Inc.
PHGE · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.77 | 2.26 | 1.18 | -0.22 |
| FCF Yield | -3.82% | -0.78% | -2.75% | -0.40% |
| EV / EBITDA | -73.14 | -119.70 | -44.31 | -239.09 |
| Quality | ||||
| ROIC | -108.20% | -136.47% | -64.10% | -52.43% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 2.09 | 0.81 | 1.03 | 0.76 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | -73.46% | 26.94% | 6.56% | -22.78% |
| Safety | ||||
| Net Debt / EBITDA | 0.63 | -0.01 | 0.51 | 1.28 |
| Interest Coverage | -14.01 | -11.52 | -13.16 | -50.73 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -380.99 | -578.72 | 0.00 | 0.00 |